Condition

Inflammatory Breast Cancer Stage IV

ClinicalTrials.gov condition label

Clinical trials4

Recruiting0

Common interventions7

Lead sponsors shown3

Clinical trials

4 shown

Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility StudyNCT06057636 · 2023-09-08

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBCNCT03184558 · 2017-07-26

Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)NCT01583426 · 2012-07-01

Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast CancerNCT01426880 · 2011-08-01

Common interventions

background treatmentDRUG1 Bemcentinib; pembrolizumabDRUG1 CarboplatinDRUG1 nab-PaclitaxelDRUG1 PaclitaxelDRUG1 Self-Administered HypnosisBEHAVIORAL1 Self-Administered White Noise HypnosisBEHAVIORAL1

Leading sponsors

GBG Forschungs GmbH2 BerGenBio ASA1 The University of Tennessee, Knoxville1

Trial status mix

COMPLETED2

TERMINATED1

WITHDRAWN1

Phase mix

PHASE22

PHASE32

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.